Argatroban Patent Expiration

Argatroban was first introduced by Sandoz Inc in its drug Argatroban on Jun 30, 2000. Other drugs containing Argatroban are Argatroban In Sodium Chloride, Argatroban In 0.9% Sodium Chloride, Argatroban In Dextrose. 14 different companies have introduced drugs containing Argatroban.


Argatroban Patents

Given below is the list of patents protecting Argatroban, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Argatroban In Sodium Chloride US7589106 Alcohol free formulation of argatroban Sep 26, 2027 Cipla
Argatroban In Sodium Chloride US7687516 Alcohol free formulation of argatroban Sep 26, 2027 Cipla
Argatroban US5214052 Method for dissolving arginineamides and pharmaceutical compositions containing them Jun 30, 2014

(Expired)

Sandoz



Argatroban's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Argatroban Generic API Manufacturers

Several generic applications have been filed for Argatroban. The first generic version for Argatroban was by Endo Operations Ltd and was approved on Jun 30, 2014. And the latest generic version is by Gland Pharma Ltd and was approved on Jul 31, 2023.

Given below is the list of companies who have filed for Argatroban generic, along with the locations of their manufacturing plants worldwide.